Angion Biomedica Corp.

NASDAQ: ANGN · Real-Time Price · USD
1.00
0.00 (0.00%)
At close: Jun 01, 2023, 10:00 PM

Angion Biomedica Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-51.9M -35.2M -38.81M -54.57M
Depreciation & Amortization
1.18M 1.17M 991K 801K
Stock-Based Compensation
1.45M n/a 885K 12.04M
Other Working Capital
n/a n/a -2.18M -25.1M
Other Non-Cash Items
n/a n/a 2.77M 12.04M
Deferred Income Tax
n/a n/a n/a 3.02M
Change in Working Capital
n/a n/a -4.23M -25.97M
Operating Cash Flow
-37.07M -32.69M -38.39M -52.64M
Capital Expenditures
-87K -66K n/a -382K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
3K 34K n/a n/a
Investing Cash Flow
-84K -32K n/a -382K
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a 7M n/a -10K
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
36.34M 38.61M -60K 107.17M
Financial Cash Flow
42.32M 38.61M -60K 107.17M
Net Cash Flow
5.19M 5.89M -38.27M 54.15M
Free Cash Flow
-37.16M -32.76M -38.39M -53.02M